3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Transitional Cell
16
Urinary Bladder Neoplasms
15
Carcinoma, Merkel Cell
10
Neoplasm Metastasis
8
Carcinoma, Renal Cell
8
Breast Neoplasms
8
Neoplasms
6
Triple Negative Breast Neoplasms
5
Melanoma
5
Ureteral Neoplasms
4
Stomach Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
4
Ovarian Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Urethral Neoplasms
3
Skin Neoplasms
3
Prostatic Neoplasms
3
Colorectal Neoplasms
3
Uterine Cervical Neoplasms
2
Small Cell Lung Carcinoma
2
Sarcoma
2
Neuroendocrine Tumors
2
Head and Neck Neoplasms
2
Endometrial Neoplasms
2
Carcinoma, Squamous Cell
2
Carcinoma, Hepatocellular
2
Uveal Melanoma
1
Urothelial Cancer
1
Turcot syndrome
1
Thymoma
1
Interventions
Nivolumab
4
Ipilimumab
3
Specimen Handling
2
Proton Therapy
2
Magnetic Resonance Spectroscopy
2
Cetuximab
2
tazemetostat
1
spartalizumab
1
pembrolizumab
1
nilotinib
1
atezolizumab
1
Zoledronic Acid
1
X-Rays
1
Tiragolumab
1
Surveys and Questionnaires
1
Radiotherapy
1
Radiosurgery
1
Phantoms, Imaging
1
Imatinib Mesylate
1
Fluorodeoxyglucose F18
1
Cyclophosphamide
1
CTLA-4 Antigen
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Chordoma
×
avelumab
×
1 year
×
Clear all
No trials found.